This website uses cookies to enhance the user experience.
21st logo
||
N

NOCTEVA AS835 903 672

Limited company
Erling Skjalgssons gate 1 7030 TRONDHEIM, Norge

NOCTEVA AS

Operating
Forskning, utvikling, produksjon, lisensiering, kjøp og salg av bioteknologiske produkter, tjenester og immaterielle rettigheter, inkludert kliniske og pre-kliniske aktiviteter, samt virksomhet som naturlig står i forbindelse med dette. Selskapet kan eie aksjer/andeler i andre selskaper.
Medisinutvikling. Biomedisinsk oppdragsforskning.

Organization

Chairman of the board
Years since formation
1 year
since Jul 31, 2025
Type
Limited company
VAT registered
Yes
Number of employees
29

Financials

Total operating income 2025
2,164,009
NOK
Annual total result 2025
118,369
NOK
Total equity 2025
6,291,869
NOK
Last update: Aug 12, 2026

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman-

Others

NameRoleShares
Accountant-
Last update: Sep 5, 2025

Ownership

No available data

Financials

in NOK

Summary

Year2025
Total operating income
2,164,009
Annual Total Result
118,369
Total assets
15,003,467
Total liabilities
8,711,599
Total equity
6,291,869

P&L

Year2025
Total operating income
2,164,009
Total operating costs
2,008,861
Operating result
155,148
Financial income/costs
-5,226
Profit before tax
149,922
Total tax & extraordinary income/cost
31,553
Annual Total Result
118,369

Balance overview

Year2025
Total fixed assets
6,030,016
Total current assets
8,973,452
Total assets
15,003,467
Short term debt
8,680,046
Long term debt
0
Total liabilities
8,711,599
Contributed capital
6,173,500
Retained earnings
118,369
Total equity
6,291,869
Total equity and liabilities
15,003,467

Classification

Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises